Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Jun-23 4:52 PM View:  | Sangamo Biosciences Inc. (SGMO) | 01-Jun-23 | Grant | 13,900 | -- | -- | 36% 38.2K to 52.1K | |
| 26-May-22 5:26 PM View: | Antares Pharma Inc. (ATRS) | 24-May-22 | Disposition | 79,645 | $5.60 | $446,012.00 | (100%) 79.64K to 0 | |
| 23-May-22 8:24 PM View: | Quince Therapeutics, Inc. (QNCX) | 19-May-22 | Grant | 24,336 | -- | -- | 100% 0 to 24.34K | |
| 01-Mar-22 5:14 PM View: | Sangamo Biosciences Inc. (SGMO) | 25-Feb-22 | Grant | 12,500 | -- | -- | 49% 25.7K to 38.2K | |
| 22-Nov-21 9:09 AM View: | Acceleron Pharma Inc (XLRN) | 19-Nov-21 | Disposition (change in control) | 1,622 | -- | -- | (100%) 1.62K to 0 | |
| 14-Jun-21 6:27 PM View: | Antares Pharma Inc. (ATRS) | 10-Jun-21 | Grant | 25,452 | $4.42 | $112,498.00 | 47% 54.19K to 79.64K | < 1% |
| 11-May-21 4:30 PM View: | Emergent BioSolutions, Inc. (EBS) | 07-May-21 | Payment of Exercise | 305 | $60.85 | $18,559.20 | (3%) 12.19K to 11.89K | 2% |
| 05-Apr-21 8:17 PM View: | Acceleron Pharma Inc (XLRN) | 05-Apr-21 | Option Exercise | 8,925 | $40.72 | $363,404.00 | 196% 4.56K to 13.49K | |
| 05-Apr-21 8:17 PM View: | Acceleron Pharma Inc (XLRN) | 05-Apr-21 | Market Option Sale (Planned) | 8,925 | $140.18 | $1,251,150.00 | (66%) 13.49K to 4.56K | (28%) |
| 05-Apr-21 8:17 PM View: | Acceleron Pharma Inc (XLRN) | 05-Apr-21 | Market Sale (Planned) | 2,939 | $140.18 | $412,004.00 | (64%) 4.56K to 1.62K | (28%) |
| 02-Apr-21 6:00 PM View: | Acceleron Pharma Inc (XLRN) | 01-Apr-21 | Option Exercise | 8,925 | $40.72 | $363,404.00 | 196% 4.56K to 13.49K | |
| 02-Apr-21 6:00 PM View: | Acceleron Pharma Inc (XLRN) | 01-Apr-21 | Market Option Sale (Planned) | 8,925 | $136.47 | $1,218,000.00 | (66%) 13.49K to 4.56K | (32%) |
| 01-Mar-21 9:05 PM View: | Sangamo Biosciences Inc. (SGMO) | 25-Feb-21 | Grant | 8,200 | -- | -- | 47% 17.5K to 25.7K | |
| 26-Feb-21 5:15 PM View: | Emergent BioSolutions, Inc. (EBS) | 24-Feb-21 | Grant | 5,883 | -- | -- | 93% 6.31K to 12.19K | |
| 02-Feb-21 6:52 PM View: | Acceleron Pharma Inc (XLRN) | 29-Jan-21 | Grant | 1,622 | -- | -- | 55% 2.94K to 4.56K | |
| 15-Jun-20 9:15 PM View: | Antares Pharma Inc. (ATRS) | 11-Jun-20 | Grant | 30,220 | $2.73 | $82,500.60 | 126% 23.97K to 54.19K | 41% |
| 20-May-20 5:21 PM View: | Sangamo Biosciences Inc. (SGMO) | 18-May-20 | Grant | 2,500 | -- | -- | 33% 7.5K to 10.0K | |
| 24-Jan-20 7:32 PM View: | Acceleron Pharma Inc (XLRN) | 22-Jan-20 | Grant | 1,377 | -- | -- | 88% 1.56K to 2.94K | |
| 14-Jun-19 5:51 PM View: | Antares Pharma Inc. (ATRS) | 13-Jun-19 | Grant | 23,973 | $2.92 | $70,001.20 | 100% 0 to 23.97K | 32% |
| 12-Jun-19 5:09 PM View: | Sangamo Biosciences Inc. (SGMO) | 10-Jun-19 | Grant | 2,500 | -- | -- | 50% 5.0K to 7.5K | |
| 29-Jan-19 5:49 PM View: | Acceleron Pharma Inc (XLRN) | 25-Jan-19 | Grant | 1,250 | -- | -- | 401% 0.31K to 1.56K | |
| 28-Jun-18 7:33 PM View: | Sangamo Biosciences Inc. (SGMO) | 26-Jun-18 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 07-Mar-18 4:11 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 05-Mar-18 | Payment of Exercise | 648 | $143.39 | $92,916.70 | (2%) 29.12K to 28.47K | (10%) |
| 05-Mar-18 4:30 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 01-Mar-18 | Grant | 8,000 | -- | -- | 38% 21.12K to 29.12K | |
| 05-Mar-18 5:23 PM View: | Acceleron Pharma Inc (XLRN) | 01-Mar-18 | Grant | 312 | -- | -- | 100% 0 to 0.31K | |
| 28-Feb-18 5:27 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 26-Feb-18 | Payment of Exercise | 525 | $147.44 | $77,406.00 | (2%) 21.65K to 21.12K | (7%) |
| 12-May-17 8:52 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 11-May-17 | Grant | 1,000 | -- | -- | 5% 21.17K to 22.17K | |
| 12-May-17 8:52 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 11-May-17 | Payment of Exercise | 641 | $155.18 | $99,470.40 | (3%) 22.17K to 21.53K | (1%) |
| 06-Mar-17 6:54 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 02-Mar-17 | Grant | 7,500 | -- | -- | 55% 13.67K to 21.17K | |
| 01-Mar-17 5:16 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 27-Feb-17 | Payment of Exercise | 571 | $136.97 | $78,209.90 | (4%) 14.24K to 13.67K | (15%) |
| 12-Aug-16 4:36 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 12-Aug-16 | Market Purchase (Planned) | 608 | $137.10 | $83,355.50 | 4% 13.57K to 14.18K | 15% |
| 13-Jul-16 8:09 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 13-Jul-16 | Market Purchase (Planned) | 580 | $143.63 | $83,304.80 | 4% 12.99K to 13.57K | 10% |
| 15-Jun-16 5:17 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 13-Jun-16 | Market Purchase (Planned) | 557 | $149.61 | $83,335.10 | 4% 12.44K to 12.99K | 5% |
| 12-May-16 6:22 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 11-May-16 | Payment of Exercise | 641 | $148.76 | $95,355.20 | (5%) 13.04K to 12.4K | (6%) |
| 15-Apr-16 4:54 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 13-Apr-16 | Payment of Exercise | 103 | $147.34 | $15,176.00 | (< 1%) 13.14K to 13.04K | (7%) |
| 13-May-15 6:41 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 11-May-15 | Grant | 7,105 | -- | -- | 100% 0 to 7.11K |